Somerset Therapeutics LLC recalls Cisatracurium Besylate Injection USP
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Subpotent product:out of specification assay results observed during long term stability testing.
- Products
-
- Cisatracurium Besylate Injection USP
- Company
- Somerset Therapeutics LLC
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 71,310 10mL vials
- About this recall
- Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial, NDC 70069-161-01; 10x10mL Multiple-dose vials per Carton, NDC 70069-161-01.